Skip to Main Content

Author Details

Wesley C Van Voorhis
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
1982
325
62
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37889572An Early Treatment With BKI-1748 Exhibits Full Protection Against Abortion and Congenital Infection in Sheep Experimentally Infected With Toxoplasma gondii.J Infect Dis2024
36777670A comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and dogs.Front Vet Sci2023
37488810Rapid Epidemic Expansion of Chikungunya Virus East/Central/South African Lineage, Paraguay.Emerg Infect Dis2023
37479700Increased interregional virus exchange and nucleotide diversity outline the expansion of chikungunya virus in Brazil.Nat Commun2023
37541693Safe and effective treatments are needed for cryptosporidiosis, a truly neglected tropical disease.BMJ Glob Health2023
37981259Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice.Exp Parasitol2023
37728609Characterization of a family I inorganic pyrophosphatase from Legionella pneumophila Philadelphia 1.Acta Crystallogr F Struct Biol Commun2023
37722671Identification of and Structural Insights into Hit Compounds Targeting <i>N</i>-Myristoyltransferase for <i>Cryptosporidium</i> Drug Development.ACS Infect Dis2023
37276438Appraisal of Fungus-Derived Xanthoquinodins as Broad-Spectrum Anti-Infectives Targeting Phylogenetically Diverse Human Pathogens.J Nat Prod2023
37243273Detection of SARS-CoV-2 in Terrestrial Animals in Southern Nigeria: Potential Cases of Reverse Zoonosis.Viruses2023
37039683Identification of Fungus-Derived Natural Products as New Antigiardial Scaffolds.Microbiol Spectr2023
37167414Photoswitchable Inhibitors to Optically Control Specific Kinase Activity.ACS Chem Biol2023
37300832Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.Cell Rep2023
37131602Rapid epidemic expansion of chikungunya virus-ECSA lineage in Paraguay.medRxiv2023
37034611Increased interregional virus exchange and nucleotide diversity outline the expansion of the chikungunya virus ECSA lineage in Brazil.medRxiv2023
36920244Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.Antimicrob Agents Chemother2023
36851745Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron.Viruses2023
34748385Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.Antimicrob Agents Chemother2022
35832325Vaccine-Linked Chemotherapy Approach: Additive Effects of Combining the <i>Listeria monocytogenes</i>-Based Vaccine Lm3Dx_NcSAG1 With the Bumped Kinase Inhibitor BKI-1748 Against <i>Neospora caninum</i> Infection in Mice.Front Vet Sci2022
35396511Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage.Nat Commun2022
36041435Accurate de novo design of membrane-traversing macrocycles.Cell2022
36032965Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron.medRxiv2022
36356052SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.Sci Immunol2022
36264993Structure of Klebsiella pneumoniae adenosine monophosphate nucleosidase.PLoS One2022
35216497Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in <i>Neospora caninum</i> and <i>Danio rerio</i>.Int J Mol Sci2022
35120605SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.Cell Host Microbe2022
35118471Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.bioRxiv2022
32277809Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial.Clin Infect Dis2021
33740373Repurposing Infectious Disease Hits as Anti-<i>Cryptosporidium</i> Leads.ACS Infect Dis2021
33821281SARS-CoV-2 immune evasion by variant B.1.427/B.1.429.bioRxiv2021
33760815Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba.PLoS One2021
33565854Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.ACS Infect Dis2021
33842901Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.Cell Rep Med2021
33504855Development of a target identification approach using native mass spectrometry.Sci Rep2021
33886614High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.PLoS One2021
34981060SARS-CoV-2 spike conformation determines plasma neutralizing activity.bioRxiv2021
34737367The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design.Sci Rep2021
34401880Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants.bioRxiv2021
34751595Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.Science2021
34482255Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo.Int J Parasitol Drugs Drug Resist2021
34655903A short-term treatment with BKI-1294 does not protect foetuses from sheep experimentally infected with Neospora caninum tachyzoites during pregnancy.Int J Parasitol Drugs Drug Resist2021
34619077Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.Cell2021
33938729Special Issue on Gut Pathogens.ACS Infect Dis2021
34210893SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.Science2021
34030110In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts.Int J Parasitol Drugs Drug Resist2021
33392924Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - μs) dynamics in the C-terminal helix at the dimer interface.Biomol NMR Assign2021
33418437One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.Vet Parasitol2021
31452171In Vitro Culture of Cryptosporidium parvum Using Hollow Fiber Bioreactor: Applications for Simultaneous Pharmacokinetic and Pharmacodynamic Evaluation of Test Compounds.Methods Mol Biol2020
31930600Toward a structome of Acinetobacter baumannii drug targets.Protein Sci2020
31930578Structures of glyceraldehyde 3-phosphate dehydrogenase in Neisseria gonorrhoeae and Chlamydia trachomatis.Protein Sci2020
  • 1 - 50 of 325

Recommended Authors

Ximena Barros-??lvarez
Stanford University School of Medicine
Career Start Year 2011
Number of shared co-authors 3
Connie Chen
University of California davis
Career Start Year 2009
Number of shared co-authors 1
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 3
Dhiraj Kumar
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Pooja Agarwal
SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, University of Cape Town
Career Start Year 2003
Number of shared co-authors 0
Shirin Arastu-Kapur
Stanford University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Malina A Bakowski
a division of The Scripps Research Institute La Jolla
Career Start Year 2003
Number of shared co-authors 2
Giselle M Knudsen
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 4
Matthias Wittwer
F. Hoffmann-La Roche Ltd.
Career Start Year 1997
Number of shared co-authors 1
Adam R Renslo
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1997
Number of shared co-authors 3
Elizabeth R Fischer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
Gabriele Pradel
RWTH Aachen University
Career Start Year 1995
Number of shared co-authors 1
Paul de Figueiredo
Texas A&M University, College Station
Career Start Year 1995
Number of shared co-authors 1
Mohammed Sajid
Qassim University
Career Start Year 1994
Number of shared co-authors 8
Subbiah Parthasarathy
New York University Grossman School of Medicine
Career Start Year 1990
Number of shared co-authors 3
Andreas Hofmann
Heidelberg University
Career Start Year 1989
Number of shared co-authors 0
Steven C Almo
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 10
Alasdair Ivens
University of Washington School of Medicine
Career Start Year 1987
Number of shared co-authors 13
Raymond J Owens
University of Oxford
Career Start Year 1986
Number of shared co-authors 5
Kasturi Haldar
Boler-Parseghian Center for Rare and Neglected Disease, University of Notre Dame
Career Start Year 1982
Number of shared co-authors 0
Jorge Eduardo Fajardo
Albert Einstein College of Medicine
Career Start Year 1982
Number of shared co-authors 3
Hans-Michael M??ller
Heidelberg University Biochemistry Center
Career Start Year 1982
Number of shared co-authors 1
Emilia Mia Sordillo
Icahn School of Medicine at Mount Sinai
Career Start Year 1981
Number of shared co-authors 1
Gregory A Buck
Virginia Commonwealth University.
Career Start Year 1978
Number of shared co-authors 1
Dyann F Wirth
The Broad Institute
Career Start Year 1977
Number of shared co-authors 9
Sharon L Reed
university of california san diego Health
Career Start Year 1976
Number of shared co-authors 3
Ross L Coppel
Nursing and Health SciencesMonash UniversityClaytonVictoriaAustralia.
Career Start Year 1975
Number of shared co-authors 1
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 2
Akhil B Vaidya
Center for Molecular Parasitology, Drexel University College of Medicine
Career Start Year 1971
Number of shared co-authors 9
James H McKerrow
Sandler Center for Drug Discovery, University of California San Francisco
Career Start Year 1970
Number of shared co-authors 12

Collaborators

Frederick S Buckner
University of Washington
Co-authored papers 70
Peter J Myler
University of Guelph
Co-authored papers 53
Christophe L M J Verlinde
University of Washington
Co-authored papers 44
Gregory J Crowther
Everett Community College
Co-authored papers 17
Donald D Lorimer
Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Co-authored papers 14
Alexandra C Walls
Co-authored papers 9
David Veesler
Co-authored papers 9
Elizabeth A Worthey
Heersink School of Medicine, The University of Alabama at Birmingham
Co-authored papers 6
Case W McNamara
a division of The Scripps Research Institute La Jolla
Co-authored papers 5
Melissa S Love
a Division of The Scripps Research Institute
Co-authored papers 5
Thomas Earnest
Washington University School of Medicine in St. Louis
Co-authored papers 5
David S Roos
University of Pennsylvania
Co-authored papers 5
Rob Hooft van Huijsduijnen
Vrije Universiteit Amsterdam (VU)
Co-authored papers 4
Sayaka Shibata
Co-authored papers 4
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 4
Lauren Carter
Co-authored papers 3
Ralph S Baric
University of North Carolina
Co-authored papers 3
Raymond Hui
University of Toronto
Co-authored papers 3
Fern??n Ag??ero
Universidad Nacional de San Martin
Co-authored papers 3
Solomon Nwaka
Institut fur Biochemie und Molekularbiologie, Universitat Freiburg
Co-authored papers 3
Aaron Riechers
Co-authored papers 3
Stuart A Ralph
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne
Co-authored papers 3
Santiago J Carmona
AGORA Cancer Research Center
Co-authored papers 3
Dhanasekaran Shanmugam
CSIR - National Chemical Laboratory
Co-authored papers 3
Wayne Conrad Liles
University of Washington
Co-authored papers 3
Mary Jane Navarro
Co-authored papers 3
Christiane Hertz-Fowler
Institute of Integrative Biology, University of Liverpool
Co-authored papers 2
Joseph L DeRisi
University of California San Francisco
Co-authored papers 2
Edward C Holmes
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers 2
Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Co-authored papers 2
Release 1.2